Primary myelofibrosis as the etiology of pulmonary alveolar proteinosis: a rare clinical scenario.

This letter to the editor discusses a rare case of a patient with primary myelofibrosis (PMF) who developed pulmonary alveolar proteinosis (PAP). The patient was successfully treated with allogeneic hematopoietic stem cell transplantation (allo-HSCT) and a tailored approach combining low-dose ruxolitinib and radiotherapy. The article highlights the potential of allo-HSCT as a treatment option for PAP and emphasizes the importance of proper management and monitoring of lung conditions before and after transplantation. The successful resolution of both diseases in this case demonstrates the effectiveness of allo-HSCT. [Extracted from the article]